CA2066313A1 - New pharmaceutical composition - Google Patents

New pharmaceutical composition

Info

Publication number
CA2066313A1
CA2066313A1 CA 2066313 CA2066313A CA2066313A1 CA 2066313 A1 CA2066313 A1 CA 2066313A1 CA 2066313 CA2066313 CA 2066313 CA 2066313 A CA2066313 A CA 2066313A CA 2066313 A1 CA2066313 A1 CA 2066313A1
Authority
CA
Canada
Prior art keywords
pharmaceutical composition
new pharmaceutical
new
imidaro
tetrazin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2066313
Other languages
French (fr)
Other versions
CA2066313C (en
Inventor
Malcolm Francis Graham Stevens
Edward Stuart Newlands
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Research Campaign Technology Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/781,020 external-priority patent/US5260291A/en
Application filed by Individual filed Critical Individual
Publication of CA2066313A1 publication Critical patent/CA2066313A1/en
Application granted granted Critical
Publication of CA2066313C publication Critical patent/CA2066313C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

8-carbamoyl-3-methyl-(3H)-imidaro(5,1-d]-1,2,3,5-tetrazin-4-one for use in the treatment of glioma or mycosis fungoides.
CA002066313A 1991-10-18 1992-04-16 New pharmaceutical composition Expired - Lifetime CA2066313C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/781,020 US5260291A (en) 1981-08-24 1991-10-18 Tetrazine derivatives
US07/781020 1991-10-18

Publications (2)

Publication Number Publication Date
CA2066313A1 true CA2066313A1 (en) 1993-04-19
CA2066313C CA2066313C (en) 2002-08-20

Family

ID=25121424

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002066313A Expired - Lifetime CA2066313C (en) 1991-10-18 1992-04-16 New pharmaceutical composition

Country Status (1)

Country Link
CA (1) CA2066313C (en)

Also Published As

Publication number Publication date
CA2066313C (en) 2002-08-20

Similar Documents

Publication Publication Date Title
CA2105487A1 (en) Antiviral nucleoside combination
CA2195213A1 (en) Use of droloxifene for the treatment of cardiovascular diseases
AU610036B2 (en) Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis inflammation and as immunosuppressants
PH30439A (en) 3,4-Dihydro-2h-1,4-benz-oxazine derivatives and pharmaceutical compositions containing the same
PH31205A (en) Pharmaceutical composition.
AP9400654A0 (en) Novel imidazole compounds, processes for the preparation thereof and their use in therapay
ZA926020B (en) Pharmaceutical combination formulation.
IL98873A0 (en) Benzodiazepine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
DE69007938D1 (en) Single and multi-layer coatings containing aluminum nitride.
CA2068871A1 (en) Non-glycosylated fgf-4 and compositions containing the same
EP0538898A3 (en) Cytotoxic bicyclo (7.3.1)-tridec-4-ene-2,6-diyne compounds and process for the preparation thereof
PH31073A (en) Pharmaceutical composition and process for the preparation thereof.
IL104706A0 (en) 3-(1h-tetrazol-5-yl)-4h-pyrido(1,2-a)pyrimidine-4-ones and process for the preparation thereof
OA09810A (en) Pharmaceutical composition.
CA2097044A1 (en) Cyclopentane- and -pentene-.beta.-amino acids
GB9123353D0 (en) New mercapto-amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
TW282455B (en)
CA2114859A1 (en) Cytotoxic and antiviral compound
IL102116A0 (en) Hetaryloxy-beta-carboline derivatives,processes for the preparation thereof,and pharmaceutical compositions containing the same
NZ234369A (en) 6-(naphthalenylethyl)-4-hydroxy-pyran-2-one derivatives and the 3,5-dihydroxyheptanoates; pharmaceutical compositions
EP0527704A3 (en) Dyestuffs, process for their preparation and the use thereof
IL100274A0 (en) Vinyl azole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
CA2066313A1 (en) New pharmaceutical composition
IL110780A0 (en) Pharmaceutical compositions containing 1,3-bis(2-carboxy-chromon-5-yloxy)-propan-2-ol for the treatment of the common cold
ZA928699B (en) Substituted 1,5-pentanediols and processes for the preparation thereof.

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry
MKEX Expiry

Effective date: 20120416